Curcumin-Loaded Gelatin Nanoparticles Cross the Blood-Brain Barrier to Treat Ischemic Stroke by Attenuating Oxidative Stress and Neuroinflammation

Overview

Journal Int J Nanomedicine

Publisher Dove Medical Press

Specialty Biotechnology

Date 2024 Nov 18

PMID 39553455

Authors

Qinglu Yang

Ruitong Li

Yigen Hong

Hongsheng Liu

Chuyao Jian

Shaofeng Zhao

Affiliations

Soon will be listed here.

Abstract

Background: Ischemic stroke is a medical emergency for which effective treatment remains inadequate. Curcumin (Cur) is a natural polyphenolic compound that is regarded as a potent neuroprotective agent. Compared to synthetic pharmaceuticals, Cur possesses minimal side effects and exhibits multiple mechanisms of action, offering significant advantages in the treatment of ischemic stroke. However, drawbacks such as poor water solubility and transmembrane permeability limit the efficacy of Cur. In recent years, nano-delivery systems have attracted great interest in the field of stroke therapy as an effective method to improve drug solubility and cross the blood-brain barrier (BBB).

Methods: In this study, a novel nanomedicine (Cur@GAR NPs) for ischemic stroke treatment was developed based on Cur-loaded gelatin nanoparticles (Cur@Gel NPs) that were then functionalized and modified with rabies virus glycoprotein (RVG29) to target brain tissue. The stability, antimicrobial properties, antioxidant properties, neuroprotective effects, neuronal cell uptake, and biocompatibility of Cur@GAR NPs were investigated in vitro. The in vivo therapeutic effect of Cur@GAR NPs on ischemic stroke was investigated in a middle cerebral artery occlusion (MCAO) rat model using the Morris water maze test and the open field test, and the potential mechanism of action was further investigated by histological analysis.

Results: The resulting Cur@GAR NPs improved the solubility of Cur and exhibited good dispersion. In vitro studies have shown that Cur@GAR NPs exhibit great antimicrobial properties, antioxidant properties and intracellular reactive oxygen species (ROS) protection. Notably, RVG29 significantly enhanced the uptake of Cur@GAR NPs by SH-SY5Y cells. Furthermore, in vivo studies verified the role of Cur@GAR NPs in reducing nerve damage and supporting neurological recovery. In the MCAO rat model, Cur@GAR NPs significantly attenuated neuroinflammation, reduced neuronal apoptosis and restored behavioral functions to a great extent.

Conclusion: Together these findings implied that Cur@GAR NPs could provide a novel and promising approach for effective ischemic stroke treatment.

Citing Articles

Carbon Nanodots-Based Polymer Nanocomposite: A Potential Drug Delivery Armament of Phytopharmaceuticals.

Debnath R, Ikbal A, Ravi N, Kargarzadeh H, Palit P, Thomas S Polymers (Basel). 2025; 17(3).

PMID: 39940566 PMC: 11819804. DOI: 10.3390/polym17030365.

References

Chen W, Jiang L, Hu Y, Fang G, Yang B, Li J . Nanomedicines, an emerging therapeutic regimen for treatment of ischemic cerebral stroke: A review. J Control Release. 2021; 340:342-360. DOI: 10.1016/j.jconrel.2021.10.020. View

Gomez-Verjan J, Zepeda-Arzate E, Santiago-de-la-Cruz J, Estrella-Parra E, Rivero-Segura N . Unraveling the Neuroprotective Effect of Natural Bioactive Compounds Involved in the Modulation of Ischemic Stroke by Network Pharmacology. Pharmaceuticals (Basel). 2023; 16(10). PMC: 10609914. DOI: 10.3390/ph16101376. View

Jiang C, Zhou Y, Chen R, Yang M, Zhou H, Tang Z . Nanomaterial-Based Drug Delivery Systems for Ischemic Stroke. Pharmaceutics. 2023; 15(12). PMC: 10748360. DOI: 10.3390/pharmaceutics15122669. View

Song W, Bai L, Yang Y, Wang Y, Xu P, Zhao Y . Long-Circulation and Brain Targeted Isoliquiritigenin Micelle Nanoparticles: Formation, Characterization, Tissue Distribution, Pharmacokinetics and Effects for Ischemic Stroke. Int J Nanomedicine. 2022; 17:3655-3670. PMC: 9393037. DOI: 10.2147/IJN.S368528. View

Poellmann M, Bu J, Hong S . Would antioxidant-loaded nanoparticles present an effective treatment for ischemic stroke?. Nanomedicine (Lond). 2018; 13(18):2327-2340. DOI: 10.2217/nnm-2018-0084. View

Zhi K, Raji B, Nookala A, Khan M, Nguyen X, Sakshi S . PLGA Nanoparticle-Based Formulations to Cross the Blood-Brain Barrier for Drug Delivery: From R&D to cGMP. Pharmaceutics. 2021; 13(4). PMC: 8067506. DOI: 10.3390/pharmaceutics13040500. View

Huang M, Zhai B, Fan Y, Sun J, Shi Y, Zhang X . Targeted Drug Delivery Systems for Curcumin in Breast Cancer Therapy. Int J Nanomedicine. 2023; 18:4275-4311. PMC: 10392909. DOI: 10.2147/IJN.S410688. View

Hu J, Tao M, Sun F, Chen C, Chen G, Wang G . Multifunctional hydrogel based on dopamine-modified hyaluronic acid, gelatin and silver nanoparticles for promoting abdominal wall defect repair. Int J Biol Macromol. 2022; 222(Pt A):55-64. DOI: 10.1016/j.ijbiomac.2022.09.052. View

Liu Z, Ran Y, Huang S, Wen S, Zhang W, Liu X . Curcumin Protects against Ischemic Stroke by Titrating Microglia/Macrophage Polarization. Front Aging Neurosci. 2017; 9:233. PMC: 5519528. DOI: 10.3389/fnagi.2017.00233. View

10.

Liu L, Ma Z, Han Q, Meng W, Wang H, Guan X . Myricetin Oligomer Triggers Multi-Receptor Mediated Penetration and Autophagic Restoration of Blood-Brain Barrier for Ischemic Stroke Treatment. ACS Nano. 2024; 18(14):9895-9916. DOI: 10.1021/acsnano.3c09532. View

11.

Ri M, Xing Y, Zuo H, Li M, Jin H, Ma J . Regulatory mechanisms of natural compounds from traditional Chinese herbal medicines on the microglial response in ischemic stroke. Phytomedicine. 2023; 116:154889. DOI: 10.1016/j.phymed.2023.154889. View

12.

Li Y, Wang H, Jin J, Yang C, Hu J, Li J . Advances in the research of nano delivery systems in ischemic stroke. Front Bioeng Biotechnol. 2022; 10:984424. PMC: 9634573. DOI: 10.3389/fbioe.2022.984424. View

13.

Zhong D, Gan Z, Zheng M, Li L, Cheng H, Luo H . Knowledge mapping of nano drug delivery systems across blood - Brain barrier from 1996 to 2022: A bibliometric analysis. Heliyon. 2023; 9(5):e15828. PMC: 10163661. DOI: 10.1016/j.heliyon.2023.e15828. View

14.

Zhou Z, Zhang X, Xu L, Lu H, Chen Y, Wu C . A self-healing hydrogel based on crosslinked hyaluronic acid and chitosan to facilitate diabetic wound healing. Int J Biol Macromol. 2022; 220:326-336. DOI: 10.1016/j.ijbiomac.2022.08.076. View

15.

Chen Y, Lu Y, Lee R, Xiang G . Nano Encapsulated Curcumin: And Its Potential for Biomedical Applications. Int J Nanomedicine. 2020; 15:3099-3120. PMC: 7200256. DOI: 10.2147/IJN.S210320. View

16.

Zhao W, Zeng M, Li K, Pi C, Liu Z, Zhan C . Solid lipid nanoparticle as an effective drug delivery system of a novel curcumin derivative: formulation, release and pharmacokinetics . Pharm Biol. 2023; 60(1):2300-2307. PMC: 9704087. DOI: 10.1080/13880209.2022.2136205. View

17.

Allen C, Bayraktutan U . Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int J Stroke. 2009; 4(6):461-70. DOI: 10.1111/j.1747-4949.2009.00387.x. View

18.

Liddelow S, Guttenplan K, Clarke L, Bennett F, Bohlen C, Schirmer L . Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017; 541(7638):481-487. PMC: 5404890. DOI: 10.1038/nature21029. View

19.

Li W, Shao C, Li C, Zhou H, Yu L, Yang J . Metabolomics: A useful tool for ischemic stroke research. J Pharm Anal. 2023; 13(9):968-983. PMC: 10568109. DOI: 10.1016/j.jpha.2023.05.015. View

20.

Zhao S, Ma L, Chu Z, Xu H, Wu W, Liu F . Regulation of microglial activation in stroke. Acta Pharmacol Sin. 2017; 38(4):445-458. PMC: 5386316. DOI: 10.1038/aps.2016.162. View